GlassScriptPhysician profile
Klara Schwarzova
NPI 1306408422
$1,363.44
in general payments reported to CMS, 2019-2025
9 companies · $757 in 2025
The $757 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $19.32 · 2021: $100 · 2022: $171 · 2023: $214 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.01 |
| Education | $197.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $392.36 | 2023-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Medtronic, INC. | $277.24 | 2022-2023 | Ligasure |
| Cook Medical LLC | $271.57 | 2025 | Zenith, Cook |
| W. L. Gore & Associates, INC. | $114.10 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Kerecis Limited | $102.29 | 2019 | |
| Kci USA, INC. | $100.01 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $66.30 | 2025 | |
| Smith+Nephew, INC. | $20.25 | 2025 | Collagenase Santyl |
| Covidien LP | $19.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Klara Schwarzova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.